Abstract
Despite decades of research, very modest advancements have been made in terms of improving outcomes in patients with gliomas. This highlights the need for preclinical animal models that more closely recapitulate the histopathology, molecular and cellular biology, and genetic heterogeneity of the human disease. Retroviral glioma models, particularly those driven by platelet-derived growth factor (PDGF), combine several of the desirable features of other model systems (i.e., xenografts and transgenic mice) yet avoid their limitations. They have proven to be powerful tools to address questions regarding cell of origin, genetic lesions necessary for tumor formation, tumor cell interactions with the brain’s microenvironment, and testing of experimental therapeutic modalities. In this chapter, we compare and contrast the existing PDGF retrovirus models with other systems and discuss what lessons and insights these models have provided so far to the extremely challenging field of glioma research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Armstrong, RC Harvath, L and Dubois-Dalcq, ME (1990) Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 27(3):400–407
Assanah, M Lochhead, R Ogden, A Bruce, J Goldman, J and Canoll, P (2006) Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci 26(25):6781–6790
Bachoo, RM Maher, EA Ligon, KL Sharpless, NE Chan, SS You, MJ Tang, Y DeFrances, J Stover, E Weissleder, R Rowitch, DH Louis, DN and DePinho, RA (2002) Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1(3):269–277
Bao, S Wu, Q Sathornsumetee, S Hao, Y Li, Z Hjelmeland, AB Shi, Q McLendon, RE Bigner, DD and Rich, JN (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66(16):7843–7848
Barth, RF (1998) Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36(1):91–102
Beadle, C Assanah, MC Monzo, P Vallee, R Rosenfeld, SS and Canoll, P (2008) The role of myosin II in glioma invasion of the brain. Mol Biol Cell 19(8):3357–3368
Bellion, A Baudoin, JP Alvarez, C Bornens, M and Metin, C (2005) Nucleokinesis in tangentially migrating neurons comprises two alternating phases: forward migration of the Golgi/centrosome associated with centrosome splitting and myosin contraction at the rear. J Neurosci 25(24):5691–5699
Bogler, O Wren, D Barnett, SC Land, H and Noble, M (1990) Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 87(16):6368–6372
Bouvier, C Bartoli, C Aguirre-Cruz, L Virard, I Colin, C Fernandez, C Gouvernet, J and Figarella-Branger, D (2003) Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells. J Neurosurg 99(2):344–350
Brockmann, MA Ulbricht, U Gruner, K Fillbrandt, R Westphal, M and Lamszus, K (2003) Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors. Neurosurgery 52(6):1391–1399; discussion 1399
Burns, JC Friedmann, T Driever, W Burrascano, M and Yee, JK (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90(17):8033–8037
Calver, AR Hall, AC Yu, WP Walsh, FS Heath, JK Betsholtz, C and Richardson, WD (1998) Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20(5):869–882
Chekenya, M and Pilkington, GJ (2002) NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours. J Neurocytol 31(6–7):507–521
Chow, LM Zhang, J and Baker, SJ (2008) Inducible Cre recombinase activity in mouse mature astrocytes and adult neural precursor cells. Transgenic Res 17(5):919–928
Colin, C Baeza, N Tong, S Bouvier, C Quilichini, B Durbec, P and Figarella-Branger, D (2006) In vitro identification and functional characterization of glial precursor cells in human gliomas. Neuropathol Appl Neurobiol 32(2):189–202
Dai, C Celestino, JC Okada, Y Louis, DN Fuller, GN and Holland, EC (2001) PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15(15):1913–1925
Dawson, MR Polito, A Levine, JM and Reynolds, R (2003) NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 24(2):476–488
Deinhardt, F (1980) Biology of primate retroviruses. In: Klein, G (ed) Viral Oncology. Raven Press, New York
Devare, SG Reddy, EP Law, JD Robbins, KC and Aaronson, SA (1983) Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis. Proc Natl Acad Sci USA 80(3):731–735
Ding, H Roncari, L Shannon, P Wu, X Lau, N Karaskova, J Gutmann, DH Squire, JA Nagy, A and Guha, A (2001) Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res 61(9):3826–3836
Doolittle, RF Hunkapiller, MW Hood, LE Devare, SG Robbins, KC Aaronson, SA and Antoniades, HN (1983) Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221(4607):275–277
Dunn, IF Heese, O and Black, PM (2000) Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neurooncol 50(1–2):121–137
Farin, A Suzuki, SO Weiker, M Goldman, JE Bruce, JN and Canoll, P (2006) Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis. Glia 53(8):799–808
Gensert, JM and Goldman, JE (2001) Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter. J Neurobiol 48(2):75–86
Giannini, C Sarkaria, JN Saito, A Uhm, JH Galanis, E Carlson, BL Schroeder, MA and James, CD (2005) Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol 7(2):164–176
Gil-Perotin, S Marin-Husstege, M Li, J Soriano-Navarro, M Zindy, F Roussel, MF Garcia-Verdugo, JM and Casaccia-Bonnefil, P (2006) Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. J Neurosci 26(4):1107–1116
Guha, A Dashner, K Black, PM Wagner, JA and Stiles, CD (1995) Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer 60(2):168–173
Guo, P Hu, B Gu, W Xu, L Wang, D Huang, HJ Cavenee, WK and Cheng, SY (2003) Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 162(4):1083–1093
Hermanson, M Funa, K Hartman, M Claesson-Welsh, L Heldin, CH Westermark, B and Nister, M (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52(11):3213–3219
Hermansson, M Nister, M Betsholtz, C Heldin, CH Westermark, B and Funa, K (1988) Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA 85(20):7748–7752
Hesselager, G Uhrbom, L Westermark, B and Nister, M (2003) Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res 63(15):4305–4309
Hu, X Pandolfi, PP Li, Y Koutcher, JA Rosenblum, M and Holland, EC (2005) mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7(4):356–368
Jackson, EL Garcia-Verdugo, JM Gil-Perotin, S Roy, M Quinones-Hinojosa, A VandenBerg, S and Alvarez-Buylla, A (2006) PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51(2):187–199
Johansson, FK Brodd, J Eklof, C Ferletta, M Hesselager, G Tiger, CF Uhrbom, L and Westermark, B (2004) Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. Proc Natl Acad Sci USA 101(31):11334–11337
Johansson, FK Goransson, H and Westermark, B (2005) Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene 24(24):3896–3905
Kaiser, MG Parsa, AT Fine, RL Hall, JS Chakrabarti, I and Bruce, JN (2000) Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model. Neurosurgery 47(6):1391–1398; discussion 1398–1399
Kumabe, T Sohma, Y Kayama, T Yoshimoto, T and Yamamoto, T (1992a) Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin. Oncogene 7(4):627–633
Kumabe, T Sohma, Y Kayama, T Yoshimoto, T and Yamamoto, T (1992b) Overexpression and amplification of alpha-PDGF receptor gene lacking exons coding for a portion of the extracellular region in a malignant glioma. Tohoku J Exp Med 168(2):265–269
Kwon, CH Zhao, D Chen, J Alcantara, S Li, Y Burns, DK Mason, RP Lee, EY Wu, H and Parada, LF (2008) Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res 68(9):3286–3294
Lee, J Kotliarova, S Kotliarov, Y Li, A Su, Q Donin, NM Pastorino, S Purow, BW Christopher, N Zhang, W Park, JK and Fine, HA (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9(5):391–403
Leveen, P Pekny, M Gebre-Medhin, S Swolin, B Larsson, E and Betsholtz, C (1994) Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8(16):1875–1887
Ligon, KL Alberta, JA Kho, AT Weiss, J Kwaan, MR Nutt, CL Louis, DN Stiles, CD and Rowitch, DH (2004) The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 63(5):499–509
Lindahl, P Hellstrom, M Kalen, M Karlsson, L Pekny, M Pekna, M Soriano, P and Betsholtz, C (1998) Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 125(17):3313–3322
Lopez, KA Waziri, AE Canoll, PD and Bruce, JN (2006) Convection-enhanced delivery in the treatment of malignant glioma. Neurol Res 28(5):542–548
Lu, QR Park, JK Noll, E Chan, JA Alberta, J Yuk, D Alzamora, MG Louis, DN Stiles, CD Rowitch, DH and Black, PM (2001) Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci USA 98(19):10851–10856
Maxwell, M Naber, SP Wolfe, HJ Galanopoulos, T Hedley-Whyte, ET Black, PM and Antoniades, HN (1990) Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86(1):131–140
Momota, H Nerio, E and Holland, EC (2005) Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo. Cancer Res 65(16):7429–7435
Nagano, N Sasaki, H Aoyagi, M and Hirakawa, K (1993) Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol 86(2):117–125
Nister, M Claesson-Welsh, L Eriksson, A Heldin, CH and Westermark, B (1991) Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. J Biol Chem 266(25):16755–16763
Nister, M Libermann, TA Betsholtz, C Pettersson, M Claesson-Welsh, L Heldin, CH Schlessinger, J and Westermark, B (1988) Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res 48(14):3910–3918
Noble, M Murray, K Stroobant, P Waterfield, MD and Riddle, P (1988) Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333(6173):560–562
Ogden, AT Waziri, AE Lochhead, RA Fusco, D Lopez, K Ellis, JA Kang, J Assanah, M McKhann, GM Sisti, MB McCormick, PC Canoll, P and Bruce, JN (2008) Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery 62(2):505–514; discussion 514–505
Phillips, HS Kharbanda, S Chen, R Forrest, WF Soriano, RH Wu, TD Misra, A Nigro, JM Colman, H Soroceanu, L Williams, PM Modrusan, Z Feuerstein, BG and Aldape, K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157–173
Pollack, IF Randall, MS Kristofik, MP Kelly, RH Selker, RG and Vertosick, FT, Jr. (1991) Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg 75(2):284–293
Ranza, E Facoetti, A Morbini, P Benericetti, E and Nano, R (2007) Exogenous platelet-derived growth factor (PDGF) induces human astrocytoma cell line proliferation. Anticancer Res 27(4B):2161–2166
Rebetz, J Tian, D Persson, A Widegren, B Salford, LG Englund, E Gisselsson, D and Fan, X (2008) Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS ONE 3(4):e1936
Roy, NS Wang, S Harrison-Restelli, C Benraiss, A Fraser, RA Gravel, M Braun, PE and Goldman, SA (1999) Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J Neurosci 19(22):9986–9995
Schaar, BT and McConnell, SK (2005) Cytoskeletal coordination during neuronal migration. Proc Natl Acad Sci USA 102(38):13652–13657
Shi, J Marinovich, A and Barres, BA (1998) Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve. J Neurosci 18(12):4627–4636
Shih, AH Dai, C Hu, X Rosenblum, MK Koutcher, JA and Holland, EC (2004) Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 64(14):4783–4789
Shoshan, Y Nishiyama, A Chang, A Mork, S Barnett, GH Cowell, JK Trapp, BD and Staugaitis, SM (1999) Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. Proc Natl Acad Sci USA 96(18):10361–10366
Singh, SK Clarke, ID Terasaki, M Bonn, VE Hawkins, C Squire, J and Dirks, PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821–5828
Soriano, P (1994) Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 8(16):1888–1896
Tang, DG Tokumoto, YM and Raff, MC (2000) Long-term culture of purified postnatal oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that plays out over months. J Cell Biol 148(5):971–984
Tchougounova, E Kastemar, M Brasater, D Holland, EC Westermark, B and Uhrbom, L (2007) Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. Oncogene 26(43):6289–6296
The Cancer Genome Atlas Research Network, McLendon, R Friedman, A Bigner, D Van Meir, EG Brat, DJ Mastrogianakis, M Olson, JJ Mikkelsen, T Lehman, N Aldape, K Alfred Yung, WK Bogler, O Vandenberg, S Berger, M Prados, M Muzny, D Morgan, M Scherer, S Sabo, A Nazareth, L Lewis, L Hall, O Zhu, Y Ren, Y Alvi, O Yao, J Hawes, A Jhangiani, S Fowler, G San Lucas, A Kovar, C Cree, A Dinh, H Santibanez, J Joshi, V Gonzalez-Garay, ML Miller, CA Milosavljevic, A Donehower, L Wheeler, DA Gibbs, RA Cibulskis, K Sougnez, C Fennell, T Mahan, S Wilkinson, J Ziaugra, L Onofrio, R Bloom, T Nicol, R Ardlie, K Baldwin, J Gabriel, S Lander, ES Ding, L Fulton, RS McLellan, MD Wallis, J Larson, DE Shi, X Abbott, R Fulton, L Chen, K Koboldt, DC Wendl, MC Meyer, R Tang, Y Lin, L Osborne, JR Dunford-Shore, BH Miner, TL Delehaunty, K Markovic, C Swift, G Courtney, W Pohl, C Abbott, S Hawkins, A Leong, S Haipek, C Schmidt, H Wiechert, M Vickery, T Scott, S Dooling, DJ Chinwalla, A Weinstock, GM Mardis, ER Wilson, RK Getz, G Winckler, W Verhaak, RG Lawrence, MS O'Kelly, M Robinson, J Alexe, G Beroukhim, R Carter, S Chiang, D Gould, J Gupta, S Korn, J Mermel, C Mesirov, J Monti, S Nguyen, H Parkin, M Reich, M Stransky, N Weir, BA Garraway, L Golub, T Meyerson, M Chin, L Protopopov, A Zhang, J Perna, I Aronson, S Sathiamoorthy, N Ren, G Wiedemeyer, WR Kim, H Won Kong, S Xiao, Y Kohane, IS Seidman, J Park, PJ Kucherlapati, R Laird, PW Cope, L Herman, JG Weisenberger, DJ Pan, F Van Den Berg, D Van Neste, L Mi Yi, J Schuebel, KE Baylin, SB Absher, DM Li, JZ Southwick, A Brady, S Aggarwal, A Chung, T Sherlock, G Brooks, JD Myers, RM Spellman, PT Purdom, E Jakkula, LR Lapuk, AV Marr, H Dorton, S Gi Choi, Y Han, J Ray, A Wang, V Durinck, S Robinson, M Wang, NJ Vranizan, K Peng, V Van Name, E Fontenay, GV Ngai, J Conboy, JG Parvin, B Feiler, HS Speed, TP Gray, JW Brennan, C Socci, ND Olshen, A Taylor, BS Lash, A Schultz, N Reva, B Antipin, Y Stukalov, A Gross, B Cerami, E Qing Wang, W Qin, LX Seshan, VE Villafania, L Cavatore, M Borsu, L Viale, A Gerald, W Sander, C Ladanyi, M Perou, CM Neil Hayes, D Topal, MD Hoadley, KA Qi, Y Balu, S Shi, Y Wu, J Penny, R Bittner, M Shelton, T Lenkiewicz, E Morris, S Beasley, D Sanders, S Kahn, A Sfeir, R Chen, J Nassau, D Feng, L Hickey, E Weinstein, JN Barker, A Gerhard, DS Vockley, J Compton, C Vaught, J Fielding, P Ferguson, ML Schaefer, C Madhavan, S Buetow, KH Collins, F Good, P Guyer, M Ozenberger, B Peterson, J and Thomson, E (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068
Tsai, JW Bremner, KH and Vallee, RB (2007) Dual subcellular roles for LIS1 and dynein in radial neuronal migration in live brain tissue. Nature Neurosci 10(8):970–979
Uhrbom, L Hesselager, G Nister, M and Westermark, B (1998) Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res 58(23):5275–5279
Uhrbom, L Hesselager, G Ostman, A Nister, M and Westermark, B (2000) Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells. Int J Cancer 85(3):398–406
van Heyningen, P Calver, AR and Richardson, WD (2001) Control of progenitor cell number by mitogen supply and demand. Curr Biol 11(4):232–241
Waterfield, MD Scrace, GT Whittle, N Stroobant, P Johnsson, A Wasteson, A Westermark, B Heldin, CH Huang, JS and Deuel, TF (1983) Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304(5921):35–39
Westermark, B Heldin, CH and Nister, M (1995) Platelet-derived growth factor in human glioma. Glia 15(3):257–263
Wolswijk, G and Noble, M (1992) Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. J Cell Biol 118(4):889–900
Wolswijk, G Riddle, PN and Noble, M (1991) Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells. Glia 4(5):495–503
Zagzag, D Amirnovin, R Greco, MA Yee, H Holash, J Wiegand, SJ Zabski, S Yancopoulos, GD and Grumet, M (2000) Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 80(6):837–849
Zhu, Y Guignard, F Zhao, D Liu, L Burns, DK Mason, RP Messing, A and Parada, LF (2005) Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8(2):119–130
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Assanah, M., Lopez, K.A., Bruce, J.N., Canoll, P. (2009). Modeling Gliomas Using PDGF-Expressing Retroviruses. In: Meir, E. (eds) CNS Cancer. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-60327-553-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-60327-553-8_1
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-552-1
Online ISBN: 978-1-60327-553-8
eBook Packages: MedicineMedicine (R0)